|Day Low/High||129.45 / 131.18|
|52 Wk Low/High||118.62 / 148.99|
U.S. markets pressed higher this week as earnings season got underway and on anticipation of a trade deal with China.
Boeing, Schlumberger and these other names could win big if China buys lots of U.S. goods to close its trade surplus.
The two companies entered into a research collaboration to investigate whether their combined efforts can help detect heart issues before they become more serious.
Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.
Jim discusses Johnson & Johnson's announced research study with Apple, provides his take on bank earnings, and let's you know what he'll be watching in the week ahead!
When markets behave irrationally, a buying opportunity is born... If the irrationality send stocks lower, not higher.
Johnson & Johnson to collaborate with Apple to assess impact of wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes
Acquisition Expands J&J's Portfolio of Science-based Dermocosmetic Beauty Products
Big pharma is shaping up to be a consolidating category in 2019.
One of pharma's biggest CEO's talks M&A action on the exchange.
Do we have to run for the hills? Not necessarily.
Jim recaps last week's informative trip to San Francisco and his interview with Tim Cook, and shares his thoughts on UnitedHealth Group ahead of Tuesday's earnings, Five Below's holiday sales numbers, Citigroup's earnings and much more!
Zamansky LLC investigates Johnson & Johnson Inc. (NYSE:JNJ) ("J&J" or the "Company") on behalf of its current and former employees for potential violations of the federal Employee Retirement Income Security Act ("ERISA") in the J&J Savings Plan (the...
JNJ's current pennant pattern creates the potential for a big move in the month of January.
In the AAP portfolio, Five Below is greatly outperforming on Monday thanks to an upgrade to "Overweight" and a price target bump to $118.
Former Attorney General of Louisiana, Charles C. Foti, Jr.
It was a rough day for U.S. equity markets as the Dow plunged 660 points.
Boeing and Caterpillar slide in the wake of Apple's bombshell sales revision.
We believe the potential of a trade deal has increased in recent weeks so we are hesitant to sell into its strength.
Zamansky LLC investigates Johnson & Johnson Inc. (NYSE:JNJ) ("J&J" or the "Company") on behalf of its current and former employees for potential violations of the federal Employee Retirement Income Security Act ("ERISA") in the J&J Retirement Savings Plan...
Are machines jumping on Johnson & Johnson's human risk headlines?
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.